Form 4: Perrigo CFO Eduardo Bezerra Reports Significant Equity Transactions, Including New RSU Grant

Perrigo Company plc's Executive Vice President and Chief Financial Officer, Eduardo Guarita Bezerra, reported the acquisition of ordinary shares through RSU conversion and a new grant of Restricted Stock Units, alongside a tax-related share disposal.

Summary

• Eduardo Guarita Bezerra, EVP & Chief Financial Officer of Perrigo Co plc (PRGO), reported transactions on June 6, 2025.
• He acquired 4,531 Ordinary Shares at a price of $26.16 per share, resulting from the conversion of Restricted Stock Units.
• Following this acquisition, his direct beneficial ownership of Ordinary Shares increased to 47,732.
• Concurrently, he disposed of 1,783 Ordinary Shares at $26.16 per share, likely for tax withholding purposes related to the RSU conversion.
• After the disposal, his direct beneficial ownership of Ordinary Shares was 45,949.
• Mr. Bezerra was granted 27,523 new Restricted Stock Units (RSUs), each representing a contingent right to receive one Perrigo Company plc ordinary share.
• These new RSUs will vest in three equal annual installments, beginning on June 6, 2026.
• The 4,531 Restricted Stock Units that were converted into ordinary shares are now fully disposed from the derivative securities table.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive due to the significant grant of new Restricted Stock Units, which aligns management incentives with long-term company performance. The share disposal is a routine tax-related event and does not indicate negative sentiment.

Positives

• The grant of 27,523 new Restricted Stock Units aligns management's incentives with long-term shareholder value creation.
• The acquisition of 4,531 ordinary shares through RSU conversion demonstrates the executive's continued equity stake in the company.

Negatives

• The disposal of 1,783 ordinary shares, although likely for tax purposes, represents a reduction in direct share ownership.

Future Outlook

The newly granted Restricted Stock Units are scheduled to vest in three equal annual installments, commencing on June 6, 2026, indicating a future alignment of executive compensation with long-term company performance.

Industry Context

This Form 4 filing reflects routine executive compensation practices within the pharmaceutical and consumer healthcare industry, where equity-based incentives like Restricted Stock Units are commonly used to align management interests with shareholder returns.

Stakeholder Impact

• Shareholders: The RSU grant reinforces management's long-term commitment and alignment with shareholder interests, potentially leading to improved performance.
• Employees: No direct impact on general employees is indicated by this filing.

Next Steps

• The newly granted Restricted Stock Units will begin vesting in three equal annual installments starting June 6, 2026.

Key Dates

Recommendation

Keywords

Perrigo, PRGO, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Grant, Share Acquisition, Share Disposal, Executive Compensation, Corporate Governance, Financial Officer